PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

ver descrição completa

Detalhes bibliográficos
Main Authors:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Formato:	Artigo
Idioma:	Russian
Publicado em:	Remedium Group LLC 2017-11-01
Colecção:	Медицинский совет
Assuntos:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Acesso em linha:	https://www.med-sovet.pro/jour/article/view/2007

Registos relacionados

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
Por: Annina S. Vischer, et al.
Publicado em: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
Por: Chinonyerem O. Iheanacho, et al.
Publicado em: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
Por: Piotr Skonieczny, et al.
Publicado em: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
Por: Yang Zhao, et al.
Publicado em: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
Por: Chibuike C. Udenigwe, et al.
Publicado em: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
Por: Kuang-Ming Liao, et al.
Publicado em: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
Por: N.D. Filipets, et al.
Publicado em: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Por: Jordan Loader, et al.
Publicado em: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
Por: Simon B. Gressens, et al.
Publicado em: (2021-02-01)

Renin-angiotensin system blockers and COVID-19
Por: Emmanuelle Vidal-Petiot, et al.
Publicado em: (2021-06-01)

Angiotensins and rheumatoid arthritis
Por: N. M. Savushkina, et al.
Publicado em: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
Por: JungMin Choi, et al.
Publicado em: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
Por: Leonard K. Wang, et al.
Publicado em: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
Por: Fabrizio Buffolo, et al.
Publicado em: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
Por: N. V. Drobotya, et al.
Publicado em: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
Por: Yipeng Fang, et al.
Publicado em: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
Por: Jilong XU, et al.
Publicado em: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
Por: Anna V. Aksenova, et al.
Publicado em: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
Por: S. V. Stolov
Publicado em: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
Por: Konstantinos Tziomalos, et al.
Publicado em: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
Por: T E Morozova
Publicado em: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
Por: K. A. Ghyamdzhyan, et al.
Publicado em: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
Por: Stine Andersen, et al.
Publicado em: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
Por: S Ravitej, et al.
Publicado em: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
Por: Hye-Jin Park, et al.
Publicado em: (2022-01-01)

Perspectives of using angiotensin receptor antagonists
Por: V V Fomin
Publicado em: (2009-06-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
Por: Steven M. Smith, et al.
Publicado em: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
Por: Ann Z. Bauer, et al.
Publicado em: (2021-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
Por: Joachim Beige
Publicado em: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
Por: José A. Carlos-Escalante, et al.
Publicado em: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
Por: Maksimov M.L., et al.
Publicado em: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
Por: M L Maksimov, et al.
Publicado em: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
Por: Hany A Al-Hussaniy, et al.
Publicado em: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
Por: Yohko Nagai, et al.
Publicado em: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
Por: M L Maksimov
Publicado em: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
Por: Kamryn E. Jones, et al.
Publicado em: (2024-06-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
Por: D.D. Ivanov, et al.
Publicado em: (2021-09-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
Por: Odifentse Mapula-e Lehasa, et al.
Publicado em: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
Por: Mishita Goel, et al.
Publicado em: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
Por: A. E. Bragina, et al.
Publicado em: (2005-12-01)